Equitable Trust CO Moderna, Inc. Transaction History

Equitable Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$101.21 - $166.61 $140,378 - $231,088	-1,387 Reduced 34.45%	2,639 $313,000
Q1 2024 Apr 25, 2024	SELL	$85.37 - $115.44 $137,104 - $185,396	-1,606 Reduced 28.52%	4,026 $429,000
Q4 2023 Jan 25, 2024	SELL	$69.51 - $104.43 $41,775 - $62,762	-601 Reduced 9.64%	5,632 $560,000
Q3 2023 Nov 07, 2023	SELL	$96.41 - $126.61 $698,972 - $917,922	-7,250 Reduced 53.77%	6,233 $643,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $6.01 Million - $8.15 Million	-50,742 Reduced 79.01%	13,483 $1.64 Million
Q1 2023 May 08, 2023	SELL	$135.66 - $197.02 $3.19 Million - $4.63 Million	-23,490 Reduced 26.78%	64,225 $9.86 Million
Q4 2022 Feb 21, 2023	SELL	$118.38 - $210.04 $749,345 - $1.33 Million	-6,330 Reduced 6.73%	87,715 $15.8 Million
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $23,614 - $38,836	200 Added 0.21%	94,045 $11.1 Million
Q2 2022 Jul 15, 2022	BUY	$117.13 - $176.59 $11 Million - $16.6 Million	93,845 New	93,845 $13.4 Million

952

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

Stay updated on Equitable Trust CO with notifications on news.